Literature DB >> 7553570

Chancroid and Haemophilus ducreyi: an update.

D L Trees1, S A Morse.   

Abstract

Haemophilus ducreyi is a fastidious gram-negative bacillus that causes the sexually transmitted infection chancroid. Chancroid is a major genital ulcerative disease in Africa, Southeast Asia, the Caribbean, and Latin America and is of increasing concern in the United States. Genital ulcerative disease and chancroid in particular have been associated with facilitating the transmission of human immunodeficiency virus. The diagnosis of chancroid based on the clinical appearance of the genital lesion or on the isolation of H. ducreyi on selective medium is relatively insensitive. However, recent advances in nonculture diagnostic tests have enhanced our ability to diagnose chancroid. There has been renewed interest in understanding the pathogenesis of H. ducreyi. In vitro and in vivo models have been developed to help identify important virulence determinants. Through the use of biochemical and molecular techniques, macromolecular components that may be important in virulence have been identified.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553570      PMCID: PMC174629          DOI: 10.1128/CMR.8.3.357

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  138 in total

1.  Iron sources for Haemophilus ducreyi.

Authors:  B C Lee
Journal:  J Med Microbiol       Date:  1991-06       Impact factor: 2.472

2.  Clear broth and plate media for culture of Haemophilus ducreyi.

Authors:  P A Totten; W E Stamm
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

3.  Atypical presentation of chancroid in a patient infected with the human immunodeficiency virus.

Authors:  J Quale; E Teplitz; M Augenbraun
Journal:  Am J Med       Date:  1990-05       Impact factor: 4.965

Review 4.  The role of iron-binding proteins in the survival of pathogenic bacteria.

Authors:  T A Mietzner; S A Morse
Journal:  Annu Rev Nutr       Date:  1994       Impact factor: 11.848

5.  Comparison of specimen collection and laboratory techniques for isolation of Haemophilus ducreyi.

Authors:  G W Hammond; C J Lian; J C Wilt; A R Ronald
Journal:  J Clin Microbiol       Date:  1978-01       Impact factor: 5.948

6.  In vitro susceptibilities of isolates of Haemophilus ducreyi from Thailand and the United States to currently recommended and newer agents for treatment of chancroid.

Authors:  J S Knapp; A F Back; A F Babst; D Taylor; R J Rice
Journal:  Antimicrob Agents Chemother       Date:  1993-07       Impact factor: 5.191

7.  Neutralizing antibodies to Haemophilus ducreyi cytotoxin.

Authors:  T Lagergård; M Purvén
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

8.  The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.

Authors:  T Lagergård
Journal:  Microb Pathog       Date:  1992-09       Impact factor: 3.738

9.  Characterization of a multiple antibiotic resistance plasmid from Haemophilus ducreyi.

Authors:  P J Willson; W L Albritton; L Slaney; J K Setlow
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

10.  Identification of a hemolytic activity elaborated by Haemophilus ducreyi.

Authors:  K L Palmer; S Grass; R S Munson
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  77 in total

1.  Development of a serological test for Haemophilus ducreyi for seroprevalence studies.

Authors:  C Elkins; K Yi; B Olsen; C Thomas; K Thomas; S Morse
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

Review 2.  Diagnostic tests for chancroid.

Authors:  D A Lewis
Journal:  Sex Transm Infect       Date:  2000-04       Impact factor: 3.519

3.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

4.  Cellular internalization of cytolethal distending toxin from Haemophilus ducreyi.

Authors:  X Cortes-Bratti; E Chaves-Olarte; T Lagergård; M Thelestam
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

Review 5.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

6.  Expression of Haemophilus ducreyi collagen binding outer membrane protein NcaA is required for virulence in swine and human challenge models of chancroid.

Authors:  Robert A Fulcher; Leah E Cole; Diane M Janowicz; Kristen L Toffer; Kate R Fortney; Barry P Katz; Paul E Orndorff; Stanley M Spinola; Thomas H Kawula
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

7.  The LspB protein is involved in the secretion of the LspA1 and LspA2 proteins by Haemophilus ducreyi.

Authors:  Christine K Ward; Jason R Mock; Eric J Hansen
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

8.  Cloning and characterization of tdhA, a locus encoding a TonB-dependent heme receptor from Haemophilus ducreyi.

Authors:  C E Thomas; B Olsen; C Elkins
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

9.  Involvement of the Haemophilus ducreyi gmhA gene product in lipooligosaccharide expression and virulence.

Authors:  B A Bauer; M K Stevens; E J Hansen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Trimeric autotransporter DsrA is a major mediator of fibrinogen binding in Haemophilus ducreyi.

Authors:  William G Fusco; Christopher Elkins; Isabelle Leduc
Journal:  Infect Immun       Date:  2013-09-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.